|
OUR EXPERTISE
BD Biosciences is the worldwide leader
in flow cytometry instrumentation and
reagents for the clinical management of
patients infected with HIV and for
research into the development of an
AIDS vaccine that could one day eradicate
the disease. Drawing on their in-depth
understanding
of immune function, BD Biosciences
scientists are working actively with
pharmaceutical and biopharmaceutical
companies to assess the efficacy of a
new class of AIDS vaccines.
|
|
|
OUR CONTRIBUTION
BD Biosciences offers
a complete portfolio
of
instrumentation, software,
monoclonal
antibodies and
research reagents
for use
by investigators and clinical
laboratories
studying cell function and
monitoring patients with
immune
system disorders.
The capabilities
of the extensive
line of BD FACS
flow cytometry
systems have
been continually
enhanced, most
recently through
the introduction of
automated systems
for sample preparation and
handling that increase
throughput and improve
the utility of BD FACSCalibur
systems.
|
|
BD is waging the war on AIDS on two fronts–
patient monitoring and disease prevention
BD Biosciences’ expertise in flow cytometry has long been
an important resource for clinical laboratories helping patients
manage their disease. The BD FACSCount instrument used
with BD FACSCount CD4 reagents and the BD FACSCalibur
system used with BD Multiset reagents are proven platforms
for monitoring the immune status of an infected patient.
BD Biosciences’ leading edge flow cytometry applications
also are found in the research environment, where it has
introduced the BD multiwell autosampler, allowing
researchers to load 96- and 384-well plates onto the high performance
BD FACSCalibur system. For scientists seeking to develop
an AIDS vaccine, the multiwell autosampler permits greater
throughput, reduced sample volume, increased flexibility
in experiment design and database-driven software for
improved analysis.
BD Biosciences’ research flow cytometry “tool kits”
provide all the components needed for experiments, along
with specific protocols for each. Among new research
reagents, the BD cytometric bead array is an assay that
helps investigators simultaneously measure multiple analytes
such as cytokines in serum samples. In addition, the BD
FastImmune cytokine system helps validate vaccine efficacy
with a focus on measuring white blood cell responses to viruses and other
infectious agents. Results can be obtained in just a few
hours, compared to days for other methods.
BD Biosciences’ flow cytometry instruments and reagents
are true platform technologies that are finding broad application
in the development of therapeutic vaccines to treat
immune function diseases, such as autoimmunity, cancer
and AIDS.
|
|
|
